Xaira Therapeutics

📍 Brisbane, United States🗓 Founded 2023👥 179 employees💰 Last funded Mar 2024
Biotechnology Research🌐 xaira.com
Website LinkedIn
Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intelligence to learn the language of life and transform how we treat disease. The company seeks to rethink the drug discovery and development process from end-to-end by bringing together leading talent across three core areas: machine learning research to better understand biology, expansive data generation to power new models, and robust therapeutic product development to treat disease. Xaira is headquartered in the San Francisco Bay Area.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2023
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Xaira Therapeutics?
Xaira Therapeutics has 2 investors on record on gritt.io, including 2 early-stage backers.
When did Xaira Therapeutics last raise funding?
The most recent investment in Xaira Therapeutics recorded on gritt.io was in March 2024.
When was Xaira Therapeutics founded?
Xaira Therapeutics was founded in 2023.
What industry is Xaira Therapeutics in?
Xaira Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Xaira Therapeutics based?
Xaira Therapeutics is headquartered in Brisbane, United States.